ERBB2 and cancer: Motivated by all these findings, we have designed and synthesised a series of pyrazolo[3,4-d]pyrimidines as novel small molecules targeting both EGFR and ErbB2 tyrosine kinases to be useful for treatment of cancer via inhibition of cell growth and induction of apoptosis.